I believe the NNWay (Novo Nordisk Way) is our compass in every decision we make, it outlines how we operate, what we aspire, our values and purpose. It's not a mere reference, it's a way of life that shapes our conduct and propels our vision and mission forward.
It’s important that we continuously lead the way and continuously walk the talk. Always ensure we are accountable, aligning our daily work with these purposes and values striving to make a positive impact on patients’ lives and the broader community.

Embedding the NNWay into everything we do ensures that we maintain our commitment to patients, foster innovation, uphold integrity and promote collaboration and respect within our teams. In August 2023 we had a facilitation where we were measured on how we are operating as an affiliate in accordance with the NNWay.
We were praised for our high ambition, strong executional capabilities and a “role model” for the Novo Nordisk Way.

In the following newsletter every unit demonstrates how they execute and live up to our core values and principles through the NNWay focusing on essential number #1:
“We create value by having a patient-centered business approach”.
With every best practice we share, let's connect it with the essentials, demonstrating their role in our progress.

Let's continue to embrace and champion the NNWay, making each day's work a vital display of our dedication as we strive to achieve our goals together.

For the CEx team, patient centricity is fundamental to their work. Every decision they make centers around the patient’s engagement and positive experience. The role of Patient Engagement Manager (Lihav) is a unique position at Novo Nordisk Israel, allowing us to focus on patient support solutions for all of our products. The focus on creating an environment where patient feedback is valued and translated into tangible improvements in service delivery is a testament to our commitment to patient-centricity.

One of the services they are most proud of is the NovoCare Obesity AI application for patients dealing with obesity. This app was developed together with the Obesity team and a digital health company. Currently we offer the NovoCare Obesity AI app for all Wegovy ^® patients on how to use the product, improve physical activity, track dosage amounts, provide reminders, and offer dietary recommendations. The information can be shared with healthcare professionals and is integrated into the patient services dashboard, which allows us to improve our services based on their usage and customer insights.

For the first time, we launched a product that has a QR code on the packages both for Wegovy^® and Rybelsus^® so that the patients can be referred directly to the patient support services. For Rybelsus^®, we refer all the patients to the website for support and information.

The CEx team is committed to helping patients with chronic conditions and will continue to strive for excellence in their patient support services.

The challenge ahead? Increasing the access to our patient support services so that more patients will benefit.

Clearer communication plans are essential to ensure HCP’s are well-informed about patient support services and refer their patients to use them.

For Inbar and the team, working at NN is more than a job - it's a mission to meaningfully improve the lives of those with chronic conditions. It's this passion that fuels the collective drive to make a difference. Let's continue to innovate and inspire, for every patient we serve.

CMR’s focus is on patient centricity. They are committed to providing new treatments and medications that are safe and of the highest quality for the benefit of our patients.

Our medical affairs team interacts with healthcare professionals to bring the latest scientific data and ensure that they have the necessary medical information to prescribe our medications in a correct manner to the appropriate patients in need, and ensure patient safety.

Our nurses' team works in collaboration with other teams to ensure that medications are used safely and effectively, by providing peer education to nurses and product trainings to relevant patients. They are focused on implementation of our patient support program, collaboratively working with teams across the affiliate on improvement of the existing app/website for patients as an example.

Our clinical operations team, together with the Clinical Medical Manager (CMM) also exemplify patient centricity. The objective is to implement NN development programs in the medical centers in Israel. During the war, they enabled a process of medications delivery to patients' homes to continue clinical trials conduct without requirement of patients traveling to hospitals.

And of course, the Regulatory affairs team, along with the Pharmacovigilance (PV) team, ensure patient safety through working on the submission, maintenance and updates of product registration files, including important clinical and safety information which is diligently gathered and processed by our constant daily work.

Last but definitely not least, our Qualified Person (QP) team ensures that the products (both clinical as well as commercial) are appropriately released and distributed to the patients.

NNWay resonates with Michal on a personal level too, with our direct, honest, and modest way of operating.

A challenge that we are currently addressing is the high demand for our products on a global scale, and improving global product availability. This is a necessity required to continue our leadership as a top-notch pharmaceutical company.

We remain committed to our goal of patient centricity and will continue to strive for excellence in all areas.

In the world of diabetes care, our patients are at the center of our daily work and business approach.

Einav and the team are redefining patient support by placing education and resource accessibility at the forefront. They understand that each diabetes patient faces unique hurdles, so information and assistance is tailored accordingly.

Through a partnership with GistMD, an insightful patient assistance program will soon be launched, assisting the patients to deal with their disease, supporting them during their onboarding with treatments and raising their awareness and knowledge with their expected patient journey.

Innovation is key; on every Rybelsus^® packaging there is a QR code and toll-free number, offering straightforward guidance on medication usage

Listening to HCP feedback is crucial. It powers tools like stickers for kids with Type 1 diabetes, simplifying their daily routine.

Looking ahead, we aim to delve deeper into the patient journey, addressing the emotional rollercoaster from diagnosis to treatment.

At NNIL, we don't just talk about patient-centricity;
we live it every day.

In the world of Finance & Operations, the area where patient centricity is very evident is Supply Chain. The F&O team are working effortlessly on the background to ensure product availability to as many patients as possible. Managing skyrocketing demand and restricted supply is a challenging situation that requires delicate handling and in many cases a lot of actions in the background (for example, product reallocations, extraordinary imports, continuous monitoring etc.) so that nothing is felt at patient level. It’s not about the sales, it’s about the treatment continuity for every patient.

Their commitment to the NNWay is more than just words, they are striving to keep the patient at the forefront of what they do and in Finance & Operations, they aim to understand the bigger picture. That’s why over the last 3 years, in every department meeting they invite speakers from functions all around the company to share what they do and discuss impact to the patients’ life from different angles.

Let's keep learning, sharing, and growing together.

Maya brings our attention to the critical role of compliance in patient support programs (PSP’s). Maya underscores the importance of these programs in helping patients navigate new treatments and adhere to their physician guidance.

Our Legal team is dedicated to ensuring that every step we take is in lockstep with both the local procedure - regulation No. 137 of the MoH, and global regulations, upholding the highest standards of ethics and compliance. The TEN (the ethics navigator) principles are not just rules to follow; they're a commitment to integrity and excellence that protects and benefits our patients and our company.

Thanks to Maya and the legal and compliance team, we can confidently deliver support programs that not only assist patients, but also align with our core values and legal requirements.

Let's continue to work together in this spirit of ethical behavior and care.

MAPA recognizes the importance of patient access to our products. Our collaboration with patient rights organizations and donations to causes such as the JDRF (Juvenile Diabetes Research Foundation) event for families living with juvenile diabetes, the I.D.F. (International Diabetes Federation) and the Ashuja'an Association for Juvenile Diabetes reflect our commitment to patient-centricity.

The pharma industry requires our products to be approved in the health basket, with several steps before patients can access them. A very recent big win in the last Basket with the addition of Ozempic^® and Rybelsus^®! As the patient cannot decide which drug to receive, we must ensure that patients have access to our medications. We achieve this through HMO’s, Shaban, and private health insurance. MAPA negotiates the best access, pricing, and communication with HMO’s, pharmacists, and clinical pharmacists to ensure the widest availability for all patients.

To improve, we aim to strengthen our collaboration with patients, organizations, and decision-makers such as the Ministry of Finance and Health. Our ultimate goal is to make patients healthy and happy by providing access at fair prices!
We remain committed to our cause and will continue to strive for excellence in all areas to improve patient access to our medications.
Together, we can make a difference.

In the pursuit of transforming obesity care and establishing obesity as a chronic disease, the obesity team is driven by a commitment to patient-centricity, aiming not just to treat but also to empower. The focus is on educating HCP’s and their patients with obesity, dispelling stigma, and uncovering the true needs of patients.

Understanding each patient's unique journey is key. Through market research and focus groups, they're mapping out the experiences of those they serve, identifying gaps where they can step in and make a difference.

A significant hurdle they've identified is the HCP's challenge in discussing obesity with patients and treating it as a chronic disease. Their goal is to facilitate these sensitive conversations, providing both support and education for HCP's and patients with their families.

At NNIL, the NNWay isn't just about an external mission, it's also about how we treat each other with empathy and respect. This culture of dignity is what makes our work not only special but truly meaningful.

In the People & Organisation (P&O) department, Keren and her team contribute to the support and implementation of our culture and the NNWay across the organisation through equipping our employees with the necessary tools, programmes and trainings. From presentation workshops that empower our teams to effectively communicate with health care practitioners (HCP’s), to meticulous recruitment and onboarding for new product launches, supporting managers and organisational processes, P&O is the backbone of our patient-centric approach.

The NNWay is not just a philosophy for Keren, it's the 'bible' that informs her decisions and aligns our affiliate with a common purpose. It's woven into the very fabric of our DNA, from the moment we recruit candidates, using the guidelines of future frontline customer engagement (FFCE) together with the CEx unit, a move from being product-centric to focusing on patient-centricity. Outstanding employees who exemplify this ethos are celebrated at our annual Kick Off awards ceremony.

Looking ahead, we see the value in broadening our horizons by giving all of our employees a holistic understanding of our organisation, and amplifying patient testimonials can only deepen our commitment to the people we serve.

Together, we'll continue to always keep the patient at the forefront and nurture our culture and bring the NNWay to life in everything we do.

At the core of Uri's work is the NNWay. Working at NNIL is not just a job for Uri and his team (with some of the longest serving employees!) - it's a heartfelt mission.

We have continuously kept our presence and lead in the Women Hormone Replacement Therapy in Israel, staying true to the mission statement “HRT is our commitment”. In a move that showcases their commitment to patient access and education in the past, Vagifem^® has been transitioned from prescription to over-the-counter, expanding its reach.

In the Growth Hormone market, they launched Israel's first patient website for growth hormone therapy. that provided a better patient experience for onboarding and supported adherence. Unfortunately, last year they experienced a severe supply shortage. They have been proactive in managing supply issues, informing the Ministry of Health six months in advance, HMO’s and HCP’s to enable them to prepare and avoid shortage. It was successful and was greatly appreciated.

They have recently launched Refixia^®, a game-changer in hemophilia B treatment, now a once weekly injection. The marketing slogan is “Refixia^® is normalizing patient life”. It reduces bleeding and aims to make life more manageable for those with chronic conditions by having to inject IV from twice a week to only once a week.

NN's School for junior EndoPedo’s has been another innovative step, equipping HCP’s with their soft skills which are not addressed but needed to enhance patient communication, medication adherence and resilience.

Through engagement with patient associations and using creative tools like puppets for young hemophilia patients, they're empowering individuals to take charge of their treatment.

Let's continue to support, innovate and care because every patient deserves our best.